StemSight - Vision unlimited
Off-the-shelf stem cell therapies to cure blindness
Limbal stem cell deficiency
Limbal stem cell deficiency (LSCD) is a rare disease with high societal burden, as it mainly affects young and working age people, who are debilitated for life. LSCD is a severe form of corneal blindness, where the natural renewal capacity of the cornea is lost. This painful and ultimately blinding condition can result from thermal or chemical burns or severe infections. Despite attempts for surgical interventions, currently no valid treatment exists for patients suffering from LSCD in both eyes.
StemSight offers a standardized treatment for these patients with the help of highly potent limbal epithelial cells obtained from human pluripotent stem cells. These cells are transplanted to the eye on a biodegradable carrier material which is easy to apply usign conventional surgical methods.
You can also watch our CEO Laura explain our approach on video
